The Scientific Research team at Immunitas Therapeutics drives the discovery and development of novel immuno-oncology therapies. Leveraging a single-cell genomics platform, the team focuses on rapid target identification and validation, alongside antibody discovery and engineering. This multidisciplinary group collaborates to translate scientific findings into clinical applications, aiming to develop breakthrough treatments for cancer.
View all